Article

Blood line = life line?

Will findings by Worcester, MA-based Advanced Cell Technologies (ACT) on large-scale blood production from stem cells help the company pull in some much-needed capital? By now you've likely seen reports on a linkurl:paper;http://bloodjournal.hematologylibrary.org/cgi/content/abstract/blood-2008-05-157198v1 appearing today in Blood in which researchers differentiated human embryonic stem cells into oxygen-carrying blood cells, in large quantity. The results suggest it may be possible to create

Written byAndrea Gawrylewski
| 1 min read
Save for Later
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
Will findings by Worcester, MA-based Advanced Cell Technologies (ACT) on large-scale blood production from stem cells help the company pull in some much-needed capital? By now you've likely seen reports on a linkurl:paper;http://bloodjournal.hematologylibrary.org/cgi/content/abstract/blood-2008-05-157198v1 appearing today in Blood in which researchers differentiated human embryonic stem cells into oxygen-carrying blood cells, in large quantity. The results suggest it may be possible to create mass quantities of blood for transfusions and blood banks. It's a promising advance in applying embryonic stem cell technology, but what's also interesting about this study is its timing. Just linkurl:last month;http://www.the-scientist.com/blog/display/54884/ ACT stated in a Security and Exchange Commission filing that the biotech did not have funds to stay open through the end of the month. All the press "might help a little" in attracting some new investment to the company, Robert Lanza, chief scientific officer at ACT and senior author on the recent paper, told The Scientist in an Email. "But most potential investors already know what we're doing." Lanza added that the company has several papers in the pipeline. Last week, the Worcester Business Journal linkurl:reported;http://www.wbjournal.com/news41387.html that ACT had licensed some of its embryonic stem cell technology and 140 stem cell lines to Embryome, a subsidiary of BioTime Inc. The upfront payment was $250,000, with the paper reporting that ACT could stand to make $1.25 million from the deal. But Lanza told the linkurl:Boston Globe;http://www.boston.com/business/healthcare/articles/2008/08/20/stem_cells_may_bring_bottomless_blood_bank/ today that the company is still scrambling for funds, "raising small amounts of money and working on larger deals."
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Join for free today
Already a member? Login Here

Meet the Author

Share

Related Research Resources

A menstrual cup and storage bag on a blue background

Collecting Insights into the Vaginal Microbiome and Menstrual Health

Article

DNA Genotek logo
An illustration of PFAS in the bloodstream.

Uncovering the Harmful Effects of PFAS Exposure on the Human Body

Infographic

An illustration of PFAS bubbles in front of a blue sky with clouds.

PFAS: The Forever Chemicals

Infographic

sartorius logo
Abstract paint splashes resembling viral particles on a colorful background.

Accelerating Pathogen Detection with Nanopore Sequencing

Whitepaper

Oxford Nanopore Technologies Logo
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina
Exploring Cellular Organization with Spatial Proteomics

Exploring Cellular Organization with Spatial Proteomics

Abstract illustration of spheres with multiple layers, representing endoderm, ectoderm, and mesoderm derived organoids

Organoid Origins and How to Grow Them

Thermo Fisher Logo

Products

Product News

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo
Abstract background with red and blue laser lights

VANTAstar Flexible microplate reader with simplified workflows

BMG LABTECH